ADCC |
antibody-dependent cell-mediated cytotoxicity |
APCs |
antigen-presenting cells |
Cat |
cathepsin |
CatG |
cathepsin G |
CCL1 |
chemokine C-C motif ligand 1 |
CSPG4 |
chondroitin sulfate proteoglycan 4 |
DCs |
dendritic cells |
D-MMSN |
doxorubicin-loaded magnetic mesoporous silica nanoparticles |
DNAM-1 |
DNAX accessory molecule 1 |
DNRII |
TGF-β-dominant-negative receptor II |
EGFR |
epidermal growth factor receptor |
EGFRvIII |
epidermal growth factor receptor variant III |
GM-CSF |
granulocyte macrophage colony-stimulating factor |
HLA |
human leukocyte antigen |
IL-2 |
interleukin 2 |
ITAM |
immunoreceptor tyrosine-based activation motif |
KIRs |
killer immunoglobulin-like receptors |
MDSCs |
myeloid-derived suppressor cells |
MHC I |
major histocompatibility complex class I |
NETs |
neutrophil extracellular traps |
MICA |
MHC class I chain-related protein A |
MICB |
MHC class I chain-related protein B |
NCR |
natural cytotoxicity receptor |
NK cells |
natural killer cells |
NKG2D |
natural killer group 2D activating receptor |
NKG2DL |
natural killer group 2D ligands |
NSPs |
neutrophil serine proteases |
PBMCs |
peripheral blood mononuclear cells |
TCR |
T cell receptor |
TGF-β |
transforming growth factor beta |
TGN |
trans-Golgi network |
Th cells |
T helper cells |
TME |
tumor microenvironment |
TNF-α |
tumor necrosis factor α |
TRAIL |
TNF-related apoptosis-inducing ligand |
Tregs |
T regulatory cells |
ULBP1–6 |
UL 16 binding protein 1–6 |